BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Treatment
16 results:

  • 1. High HPK1
    Zhang J; Ren Z; Hu Y; Shang S; Wang R; Ma J; Zhang Z; Wu M; Wang F; Yu J; Chen D
    Int Immunopharmacol; 2024 Jan; 127():111363. PubMed ID: 38101218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC.
    Ye D; Jin Y; Weng Y; Cui X; Wang J; Peng M; Song Q
    Sci Rep; 2023 Sep; 13(1):16468. PubMed ID: 37777573
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Peripheral Blood Laboratory Test Results Combined with tcf1+CD8+ T Lymphocytes 
Ratio to Predict the Response and Prognosis of Immunotherapy to 
Advanced lung cancer].
    Luo H; Dai S; Li Y; Tian P; Li Q; Cai X
    Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):605-614. PubMed ID: 37752540
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma.
    Gaglia G; Burger ML; Ritch CC; Rammos D; Dai Y; Crossland GE; Tavana SZ; Warchol S; Jaeger AM; Naranjo S; Coy S; Nirmal AJ; Krueger R; Lin JR; Pfister H; Sorger PK; Jacks T; Santagata S
    Cancer Cell; 2023 May; 41(5):871-886.e10. PubMed ID: 37059105
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy.
    Maniar R; Wang PH; Washburn RS; Kratchmarov R; Coley SM; Saqi A; Pan SS; Hu J; Shu CA; Rizvi NA; Henick BS; Reiner SL
    Cancer Immunol Res; 2023 Feb; 11(2):164-170. PubMed ID: 36512052
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell lung cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
    Kim KH; Pyo H; Lee H; Oh D; Noh JM; Ahn YC; Yoon HI; Moon H; Lee J; Park S; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Ku BM; Ahn MJ; Shin EC
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):415-425. PubMed ID: 35150786
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
    Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer HM; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Foroughi Asl H; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Gram Hansen C; Drageset Haakensen V; Helland Å; Tamborero D; Johansson HJ; Branca RM; Planck M; Staaf J; Orre LM
    Nat Cancer; 2021 Nov; 2(11):1224-1242. PubMed ID: 34870237
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Blocking Short-Form Ron Eliminates Breast cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression.
    Lai SA; Gundlapalli H; Ekiz HA; Jiang A; Fernandez E; Welm AL
    Cancer Discov; 2021 Dec; 11(12):3178-3197. PubMed ID: 34330779
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. lncRNA hnf1a-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Study on the Difference of Gene Expression between Central and Peripheral lung Squamous Cell Carcinoma Based on TCGA Database].
    Li W; Li Y; Zhang H; Li Y; Yuan Y; Gong H; Wei S; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):280-288. PubMed ID: 31109437
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long non-coding RNA hnf1a-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G; An X; Zhao H; Zhang Q; Zhao H
    Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
    Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
    Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bronchoscopic intervention obviates the need for continued mechanical ventilation in patients with airway obstruction and respiratory failure from inoperable non-small-cell lung cancer.
    Murgu S; Langer S; Colt H
    Respiration; 2012; 84(1):55-61. PubMed ID: 22759948
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. WNT2 and human gastrointestinal cancer (review).
    Katoh M
    Int J Mol Med; 2003 Nov; 12(5):811-6. PubMed ID: 14533014
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity.
    Ingelman-Sundberg M; Johansson I; Persson I; Oscarson M; Hu Y; Bertilsson L; Dahl ML; Sjöqvist F
    EXS; 1994; 71():197-207. PubMed ID: 8032151
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.